Amgen AMGN
NASDAQ AMGN
$403.04 -4.23 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amgen (AMGN) Long-Term Investments (2013 - 2014)

Updated

Amgen (AMGN) posted Long-Term Investments of $3.41 billion for Q1 2014, up 0.1% from the prior quarter.

Analysis

Amgen (AMGN) Long-Term Investments (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 266.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.56 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn 5.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 3.41 Bn
Dec 31, 2013 3.41 Bn
Sep 30, 2013 3.41 Bn
API Access

Amgen Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=AMGN&period=max&api_key=YOUR_API_KEY